Navigation Links
First Patients Enrolled in the Access-Europe Study of The MitraClip(R) Therapy
Date:4/6/2009

European Post Market Observational Study Intended to Collect Data to Demonstrate the Clinical and Health Economic Benefits of the MitraClip(R) Therapy for Patients with Mitral Regurgitation

MENLO PARK, Calif., April 6 /PRNewswire/ -- Evalve, Inc., the leader in the development of devices for the percutaneous repair of cardiac valves, announced today the first enrollment in the ACCESS-Europe study, a post-market observational study of the MitraClip(R) therapy in Europe. The MitraClip(R) system is the first commercially available treatment option for non-surgical mitral valve repair for patients suffering from the effects of functional and degenerative mitral regurgitation (MR).

MR affects millions of people worldwide and is the most common type of heart valve insufficiency in Europe and the United States. In Europe, similar to the US, there are approximately 250,000 new diagnoses of significant MR each year; however, only 20 percent or approximately 50,000 of these patients undergo surgery each year. Non-surgical patients and many of the higher risk surgical patients continue to be affected by the chronic volume overload caused by MR, which requires the heart to work harder, which may lead to heart failure and hospitalization.

The first patients were enrolled in ACCESS-Europe by a team led by Professor Corrado Tamburino, M.D.; Gian Paolo Ussia, M.D.; Salvatore Scandura, M.D.; and Sarah Mangiafico, M.D. at Ferrarotto Hospital at Catania University in Sicily, Italy.

"ACCESS-Europe will provide important clinical care and health economic information about the MitraClip(R) therapy," said Professor Tamburino, chair of cardiology, cardiology department, cardiac catheterization and interventional cardiology, Ferrarotto Hospital, University of Catania, Sicily. "This data will allow us to further understand the benefits of the MitraClip(R)
'/>"/>

SOURCE Evalve, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Social Security Administration First to Go Live With CONNECT Solution for Nationwide Health Information Network
2. Video: New First Response(R) Fertility Test Helps Women Answer the Question: Am I Able to Get Pregnant?
3. Imagine No More Waits for Emergency Room Care ... InQuickER Chooses Trevelino/Keller Communications to Launch First Service of Its Kind
4. I-Therapeutix Announces First Commercial Use of I-ZIP(R) Adherent Ocular Bandage for Clear Corneal Cataract Incisions
5. First Patients Treated in India Using CyberKnife Radiosurgery
6. Zimmer Holdings Announces Live Audio Webcast and Conference Call of First Quarter 2009 Results
7. World-first high blood pressure treatment trialled in Melbourne
8. Covance Inc. Invites You to Join the Webcast of Its First Quarter 2009 Financial Results Conference Call
9. Berlin Heart Receives First Regulatory Approval in North America
10. NIH releases the first research plan to reduce the burden of digestive diseases
11. LodgeNet Healthcare Provides Industrys First Integrated High-Definition Interactive System for Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... hadn,t spread, study finds , , MONDAY, Dec. 14 (HealthDay ... death in male colon cancer survivors, researchers report. , ... men who,d been treated for stage I, stage II ... (nonmetastatic cancer). Every two years, the men were sent ... disease diagnoses, as well as their physical activity. A ...
(Date:12/14/2009)... are linked to an increased risk of certain cancers. ... synthetic insulin preparation marketed under the trade name Lantus), ... cancers than other insulins or oral glucose lowering medications. ... important factors such as obesity that may have driven ... large randomized trial designed to examine another aspect of ...
(Date:12/14/2009)... and Accurately for Biopsy , ... ... Diagnostics announced today that the U.S. Food and Drug Administration ... molecular imaging biopsy guidance. , , ,GammaLMc® is a ... Camera. The GammaLMc® (GL) system will help doctors accurately locate ...
(Date:12/14/2009)... show consistent rate of lacerations, accidental ingestion of ... Dec. 14 A new study from ... found that holiday decorations, particularly glass ornaments, are ... the season. A review of records from Children,s ... injuries per year, more than half of these ...
(Date:12/14/2009)... Only about one in 2,000 people in the United States ... the unfortunate few. , Ms. Wilcox,s tumor was a classic ... problems were mistaken for blocked sinuses. , "For several months, ... nose," recalled the resident of Goldthwaite, a town of less ... felt a fullness, but I didn,t take that as something ...
Breaking Medicine News(10 mins):Health News:Physical Activity May Prolong Survival After Colon Cancer 2Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2Health News:Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA 2Health News:Parents: Be Mindful of Hazardous Holiday Ornaments 2Health News:Parents: Be Mindful of Hazardous Holiday Ornaments 3Health News:Minimally invasive surgery removes sinus tumor without facial disfiguration 2
... Ramanathapuram District Collector, K. Sellamuthu, has ordered distribution of ... // such as tea stalls, hair cutting saloons ... are the places where large number of public gather. ... the Tamilnadu State AIDS Control Society (TANSACS), according to ...
... exception. To all those who wish kick the habit and ... Smokers // world over are swearing by Laser ... likened to a modern form of acupuncture has recorded higher ... most other smoking cessation programmes. For the first time, residents ...
... that is on the migratory route of wild birds had so ... ,But the latest news about the death of a 14-year-old ... only in Asia with the death toll about 70. ... being the cause of death of the Turkish boy. The boy ...
... of Padua have found that the some complications ... and immediately after birth) could play a major role ... as anorexia nervosa and bulimia nervosa. ,Previous ... by a complex interplay of genetic and environmental factors. ...
... of health reports that infectious diseases in China has ... and eradication// programs organized by the Chinese government but, ... urban population still there is a threat for infectious ... and malnutrition. China has seen a drop in air ...
... doctors of Indian origin live in a state of penury in ... of them even have decent // lodgings. This is the ... to serve in the country in 2001, which had resulted in ... ,Most of them are faced with discrimination and unemployment ...
Other Medicine News:Health News:Zap the butt (cigarette) with Laser Therapy 2Health News:Complications During Delivery Related To Eating Disorders 2
(Date:12/14/2009)... Accuray Incorporated (Nasdaq: ARAY ), ... announced today that the first CyberKnife® Robotic Radiosurgery ... University Hospital of Liege. ,, The University ... of the largest hospitals in Euregio, a cross-country ... a full range of cancer treatments, University Hospital ...
(Date:12/14/2009)... Inc. (Nasdaq: MYL ) today announced that ... Index Dec. 21. Mylan,s common shares will also ... Chairman and CEO Robert J. Coury said: "We ... followed index of leading companies. This development marks ... the rapid growth and strong potential of our ...
(Date:12/14/2009)... The U.S. Food and Drug Administration ... Injectable Suspension for the treatment of schizophrenia in ... LLY ) announced today. ZYPREXA RELPREVV, a long-acting ... up to four weeks. ,, Different from both ... antipsychotics allow for stable concentrations of the active ...
Breaking Medicine Technology:First CyberKnife in Belgium to be Installed at Leading University Hospital 2First CyberKnife in Belgium to be Installed at Leading University Hospital 3Mylan Added to NASDAQ-100 Index 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 14956 1Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 14956 2Zimmer Holdings to Present at 21st Annual Piper Jaffray Health Care Conference 6502 1Orexigen 28R 29 Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635 28c 29 284 29 6498 1Orexigen 28R 29 Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635 28c 29 284 29 6498 2Orexigen 28R 29 Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635 28c 29 284 29 6498 3
... Introduction ,Automation continues to gain importance ... increasing test consolidation, rising demands from clinicians ... shortage of licensed medical technologists. Ultimately, the ... better equipped to meet these modern demands. ...
... Editor ,Since the first system was ... clinical medicine and patient care. During the 1960s, ... blood gases were considered "the most important laboratory ... www.bloodgas.org article by Dr. John Severinghaus, inventor of ...
Other Medicine Technology:Optimizing Quality Control Data Management 2Optimizing Quality Control Data Management 3Optimizing Quality Control Data Management 4Optimizing Quality Control Data Management 5Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing 2Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing 3Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing 4
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: